DAISY – Specific Aim 3

This project aims to measure acceptability of, and preferences for the DAISY drug delivery platform among two key end-user groups in South Africa (SA): caregivers of HIV-positive children receiving antiretroviral therapy (ART) and health care providers.

These end-user perspectives are linked to the Target Product Profile (TPP) and will inform design of the DAISY, including device and applicator characteristics.

Latest Update: 15 February 2021

For more about DAISY – Specific Aim 3 please email rhicomms@wrhi.ac.za